scholarly journals Corrigendum: Depression as a Risk Factor for Impulse Control Disorders in Parkinson Disease

2020 ◽  
Vol 88 (1) ◽  
pp. 205-205
Author(s):  
Juan Marín‐Lahoz ◽  
Frederic Sampedro ◽  
Saül Martinez‐Horta ◽  
Javier Pagonabarraga ◽  
Jaime Kulisevsky
Keyword(s):  
Risk Factor ◽  
Parkinson Disease ◽  
Impulse Control ◽  
Impulse Control Disorders

Depression as a Risk Factor for Impulse Control Disorders in Parkinson Disease

2019 ◽  
Vol 86 (5) ◽  
pp. 762-769 ◽  
Author(s):  
Juan Marín‐Lahoz ◽  
Frederic Sampedro ◽  
Saül Martinez‐Horta ◽  
Javier Pagonabarraga ◽  
Jaime Kulisevsky
Keyword(s):  
Risk Factor ◽  
Parkinson Disease ◽  
Impulse Control ◽  
Impulse Control Disorders

P5-2 Theta subthalamic activity in impulse control disorders in Parkinson disease

2010 ◽  
Vol 121 ◽  
pp. S127
Author(s):  
M. Alegre ◽  
M.C. Rodriguez-Oroz ◽  
J. Lopez-Azcarate ◽  
D. Garcia ◽  
J. Toledo ◽  
...  
Keyword(s):  
Parkinson Disease ◽  
Impulse Control ◽  
Impulse Control Disorders

Impulse control disorders in Parkinson’ disease: the role of personality and cognitive status

2012 ◽  
Vol 259 (11) ◽  
pp. 2269-2277 ◽  
Author(s):  
Michele Poletti ◽  
Ubaldo Bonuccelli
Keyword(s):  
Parkinson Disease ◽  
Impulse Control ◽  
Cognitive Status ◽  
Impulse Control Disorders

Detection of Impulse Control Disorders in Parkinson Disease Patients

2010 ◽  
Vol 16 (6) ◽  
pp. 406-407 ◽  
Author(s):  
Howard D. Weiss ◽  
Elaina S. Hirsch ◽  
James R. Williams ◽  
Leah Swearengin ◽  
Laura Marsh
Keyword(s):  
Parkinson Disease ◽  
Impulse Control ◽  
Impulse Control Disorders

Parkinson disease and impulse control disorders: a review of clinical features, pathophysiology and management

2009 ◽  
Vol 85 (1009) ◽  
pp. 590-596 ◽  
Author(s):  
K Wu ◽  
M Politis ◽  
P Piccini
Keyword(s):  
Parkinson Disease ◽  
Clinical Features ◽  
Impulse Control ◽  
Impulse Control Disorders

scholarly journals Is Rapid Eye Movement Sleep Behavior Disorder a Risk Factor for Impulse Control Disorder in Parkinson Disease?

2020 ◽  
Vol 88 (4) ◽  
pp. 759-770
Author(s):  
Maria Livia Fantini ◽  
Janel Fedler ◽  
Bruno Pereira ◽  
Daniel Weintraub ◽  
Ana‐Raquel Marques ◽  
...  
Keyword(s):  
Risk Factor ◽  
Parkinson Disease ◽  
Eye Movement ◽  
Impulse Control ◽  
Behavior Disorder ◽  
Impulse Control Disorder ◽  
Rapid Eye Movement ◽  
Rapid Eye Movement Sleep ◽  
Sleep Behavior

A Single-Center, Cross-Sectional Prevalence Study of Impulse Control Disorders in Parkinson Disease

2013 ◽  
Vol 33 (5) ◽  
pp. 691-694 ◽  
Author(s):  
Michele Poletti ◽  
Chiara Logi ◽  
Claudio Lucetti ◽  
Paolo Del Dotto ◽  
Filippo Baldacci ◽  
...  
Keyword(s):  
Parkinson Disease ◽  
Impulse Control ◽  
Impulse Control Disorders ◽  
Prevalence Study ◽  
Single Center ◽  
Cross Sectional

scholarly journals The risky business of dopamine agonists in Parkinson disease and impulse control disorders.

2011 ◽  
Vol 125 (4) ◽  
pp. 492-500 ◽  
Author(s):  
Daniel O. Claassen ◽  
Wery P. M. van den Wildenberg ◽  
K. Richard Ridderinkhof ◽  
Charles K. Jessup ◽  
Madaline B. Harrison ◽  
...  
Keyword(s):  
Parkinson Disease ◽  
Impulse Control ◽  
Dopamine Agonists ◽  
Impulse Control Disorders ◽  
Risky Business

scholarly journals Trait Anxiety as a Risk Factor for Impulse Control Disorders in de novo Parkinson’s Disease

2021 ◽  
pp. 1-9
Author(s):  
Pauline Waskowiak ◽  
Vincent Koppelmans ◽  
Marit F.L. Ruitenberg
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Risk Factor ◽  
Trait Anxiety ◽  
Impulse Control ◽  
De Novo ◽  
Impulse Control Disorders ◽  
Motor Symptoms ◽  
Depression And Anxiety

Background: In addition to the well-known motor symptoms, patients with Parkinson’s disease (PD) also frequently experience disabling non-motor symptoms including impulse control disorders (ICDs). ICDs are characterized by a loss of voluntary control over impulses, drives, or temptations regarding excessive hedonic behavior. Objective: The present study examined whether depression and anxiety in de novo PD patients predict the prospective development of ICDs. Methods: We selected 330 de novo PD patients from the Parkinson’s Progression Markers Initiative database who were free of ICDs at the start of the study. ICD presence at baseline and follow-up assessments was evaluated via the shortened version of the Questionnaire for Impulsive-Compulsive Disorders (QUIP-S). Baseline depression and anxiety were measured via the Geriatric Depression Scale (GDS-15) and State-Trait-Anxiety Inventory (STAI-Y), respectively. Results: A total of 149 participants (45.2%) developed an ICD at follow-up and average time of ICD onset was 35 months after baseline. Results of a Cox regression analysis showed that STAI-Y scores but not GDS-15 scores significantly predicted ICD presence. Specifically, scores reflecting higher trait anxiety were associated with an increased risk of developing an ICD. This effect was not confounded by age, gender or UPDRS motor score. We also replicated the well-established result that dopamine agonist use is predictive of ICDs. Conclusion: Our findings indicate that higher anxiety levels in de novo PD patients represent a risk factor for ICD development during the course of the disorder. This highlights the need for early and routine based anxiety screening in these patients.

Sign in / Sign up

Export Citation Format

Share Document